Van Tuyl Christopher 4

4 · Immunovant, Inc. · Filed Apr 10, 2026

AI-generated summary of this filing

Updated Apr 10, 2026

Immunovant (IMVT) CLO Christopher Van Tuyl Sells Shares

What Happened

Christopher Van Tuyl, Chief Legal Officer of Immunovant (IMVT), sold 5,165 shares in an open-market/private sale on April 8, 2026 for a weighted average price of $24.83, generating proceeds of approximately $128,247. This sale was to satisfy tax withholding tied to RSUs that vested and was not a discretionary sell decision.

Key Details

Transaction date: April 8, 2026; Form 4 filed April 10, 2026 (filed two days after the trade).
Transaction type/code: Sale (S); proceeds ≈ $128,247.
Price: weighted average $24.83; individual trade prices ranged from $24.54 to $25.39 (see footnote F2).
RSU background: On April 1, 2025 the reporting person was granted 50,787 RSUs; 12,696 RSUs vested on April 1, 2026. The 5,165 shares sold were to cover tax withholding on that vesting (footnote F1).
Shares owned after transaction: Not specified in the summary filing — see the Form 4 for total beneficial ownership details.
Filing timeliness: Reported within two business days of the transaction (timely).

Context

This was a "sell-to-cover" tax withholding sale tied to vested restricted stock units, which companies often mandate; such transactions typically reflect tax obligations rather than a judgment about the company's prospects. The filer offers to provide, upon request, the breakdown of how many shares sold at each price within the reported range.

Form 4

Period: 2026-04-08

Chief Legal Officer

Transactions

Footnotes (2)

[F1]On April 1, 2025, the holder was granted 50,787 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 12,696 of these RSUs vested on April 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.54 - $25.39 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Signature

/s/ Tiago Girao, attorney-in-fact for Christopher Van Tuyl|2026-04-10

1 file